Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for: Control and prevention of bleeding episodes; Routine prophylaxis to prevent or reduce the frequency of bleeding episodes; Perioperative management (surgical prophylaxis).
ADYNOVATE is not indicated for the treatment of von Willebrand disease.

Adynovate Indications/Uses

Manufacturer:

Takeda

Distributor:

Zuellig

Firma Chun Cheong